Bio-Rad Laboratories | BIO - مصاريف البيع والإدارة

سعر السهم
269.85
التغيير اليومي
-9.18 -3.29%
شهريا
-8.49%
سنويا
3.45%
Q1 التوقعات
269.92




مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.13B 125M 2025-12
Agilent USD 476M 48M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Bruker USD 247.2M 4.7M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 2.03B 35M 2025-12
Exact Sciences USD 491.64M 35.94M 2025-09
General Electric Aerospace USD 1.58B 385M 2025-12
Hologic USD 2.5B 2.24B 2025-12
Illumina USD 283M 27M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Merck USD 2.85B 215M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 129M 1.3M 2025-09
OraSure Technologies USD -0.06 0.05 2024-09
Pacific Biosciences Of California USD 43.75M 2.13M 2024-09
Quest Diagnostics USD 504M 3M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Siemens EUR 3.61B 489M 2025-12
Standard Biotools USD 26.6M 1.5M 2025-09
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Tosoh JPY 41.52B 2.62B 2025-12
Waters USD 240.01M 25.78M 2025-12